Disease modifying activity of HWA 486 in rat adjuvant-induced arthritis (original) (raw)

Abstract

HWA 486 was investigated for its ability to modify the development of adjuvant-induced polyarthritis in Lewis rats. HWA 486 (20 mg/kg/day p.o.), dosed for 8 or 16 days beginning with the day of adjuvant administration, significantly reduced edema, fibrinogen levels, and erythrocyte sedimentation rates (ESR) 42 days later. When HWA 486 (20 mg/kg/day, p.o.) and cyclosporin A (CsA 15 mg/kg/day, p.o.) were tested in the 8-day treatment regimen, the antiarthritic effects of HWA 486 were more sustained. Both compounds reduced the delayed hypersensitivity (DTH) response on day 9 followed by a rebound to an enhanced DTH response on day 21. The PHA-induced mitogenic response of splenocytes from arthritic rats was suppressed on day 9. Treatment with HWA 486 but not CsA restored the splenocyte response to the level of the negative controls.

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. R. R. Bartlett and R. Schleyerbach,Immunopharmacological profile of a novel isoxazol derivative, HWA 486, with potential antirheumatic activity — I. Disease modifying action on adjuvant arthritis of the rat. Int. J. Immunopharmac.7, 7–18 (1985).
    Article Google Scholar
  2. R. R. Bartlett,Immunopharmacological profile of HWA 486, a novel isoxazol derivative — II. In vivo immunomodulating effects differ from those of cyclophosphamide, prednisolone or cyclosporin A. Int. J. Immunopharmac.8, 199–204 (1986).
    Article Google Scholar

Download references

Author information

Authors and Affiliations

  1. Pharmacology Department, Gastrointestinal and Metabolic Diseases Research, Bristol-Myers Company, 13221, Syracuse, NY, USA
    R. D. Pasternak, N. S. Wadopian, R. N. Wright, P. Siminoff, J. A. Gylys & J. P. Buyniski

Authors

  1. R. D. Pasternak
    You can also search for this author inPubMed Google Scholar
  2. N. S. Wadopian
    You can also search for this author inPubMed Google Scholar
  3. R. N. Wright
    You can also search for this author inPubMed Google Scholar
  4. P. Siminoff
    You can also search for this author inPubMed Google Scholar
  5. J. A. Gylys
    You can also search for this author inPubMed Google Scholar
  6. J. P. Buyniski
    You can also search for this author inPubMed Google Scholar

Rights and permissions

About this article

Cite this article

Pasternak, R.D., Wadopian, N.S., Wright, R.N. et al. Disease modifying activity of HWA 486 in rat adjuvant-induced arthritis.Agents and Actions 21, 241–243 (1987). https://doi.org/10.1007/BF01966478

Download citation

Keywords